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The risk of permanent hypoparathyroidism following thyroid and parathyroid surgery is around 1% in the hands of experienced
endocrinesurgeons.Althoughthiscomplicationisrare,renderingapatientpermanentlyaparathyroidhassigniﬁcantconsequences
on the health and quality of life of the patient. Immediate autotransplantation of parathyroid glands that are injured or
unintentionally removed oﬀers the best possibility of graft viability and functionality. However, since the majority of cases of
hypoparathyroidism are transient, immediate autotransplantation can complicate postoperative surveillance in certain patients,
especially those with primary hyperparathyroidism. Cryopreservation of parathyroid tissue is an alternate technique that was
developed to treat patients with permanent hypoparathyroidism. This method allows for parathyroid tissue to be stored and then
autotransplanted in a delayed fashion once permanent hypoparathyroidism is conﬁrmed. This article provides a contemporary
review on cryopreservation of parathyroid tissue and its current role in thyroid and parathyroid surgery.
1.Introduction
Permanent postoperative hypoparathyroidism results
from the unintentional removal or injury of parathyroid
glands during thyroid and parathyroid surgery. Permanent
hypoparathyroidism is deﬁned as persistent hypocalcemia
requiring calcium and vitamin D supplementation 6 months
after surgery [1]. The development of hypoparathyroidism
is contingent on the type of operation performed. The risk
is nominal during a minimally invasive parathyroidectomy
for a single adenoma but is greatest after a subtotal or
total parathyroidectomy, thyroid resection and nodal
dissection for large and extensive thyroid cancers, and
reoperative neck operations [1]. Even though the risk of
transient hypocalcemia can be high during an extensive
neck dissection, the permanent hypoparathyroidism rate is
typically around 1% in the hands of experienced endocrine
surgeons at high-volume centers.
The accidental onset of permanent hypoparathyroidism
can be agonizing for the patient and the clinician alike. For
the patient, its negative impact includes a reduced qual-
ity of life, expensive lifelong medication supplementation,
frequent laboratory testing, and the potential for frequent
hospital admissions. In addition, the persistent absence of
parathyroid hormone (PTH) has long-term systemic eﬀects
on the body, such as the development of osteoporosis (due to
the decreased function of osteocytes), premature cataracts,
cardiac dysfunction, and neurologic dysfunction [1, 2].
In the late 1960s and 1970s, several new techniques
were introduced in an attempt to prevent the detrimental
health and social consequences of permanent hypoparathy-
roidism. For example, intraoperative autotransplantation
of parathyroid tissue into the sternocleidomastoid muscle
or the brachioradialis muscle was recommended. However,
not all patients at risk of permanent hypoparathyroidism
actually develop it, nor do all patients require an immediate
autotransplant. In fact, an unnecessary autotransplant, if
performedduringparathyroidsurgery,couldresultinpersis-
tent hyperparathyroidism. Additionally, the autograft could
become autonomously hyperfunctional, posing a diagnostic
and treatment dilemma in the future; Wells et al. overcame
that limitation and transformed our approach to prevent
hypoparathyroidism by introducing autotransplantation of
cryopreserved parathyroid tissue [3].
Cryopreservation permits parathyroid tissue to be stored
for potential reimplantation, thereby avoiding the risk
of needlessly implanting parathyroid tissue during initial
surgery.Theclinicianisabletoaccuratelydeterminewhether
any residual parathyroid tissue will recover function or
whether a delayed autotransplant will be needed [4]. Most2 International Journal of Endocrinology
Table 1: Indications for parathyroid cryopreservation.
Initial neck operations Redo neck operations
Multigland parathyroid hyperplasia Parathyroidectomy after thyroidectomy
– Familial primary hyperparathyroidism (PHPT) Persistent hyperparathyroidism
– Secondary hyperparathyroidism (SHPT) Recurrent hyperparathyroidism
– Tertiary hyperparathyroidism (THPT) Redo central neck dissection for thyroid cancer
Total thyroidectomy with central neck dissection
patients with postoperative hypoparathyroidism have the
condition only transiently. The disadvantages of cryopreser-
vation of parathyroid tissue include the potential of graft
failure and the risk of graft-dependent hypercalcemia [5].
This paper provides an up-to-date, comprehensive review
of the cryopreservation of parathyroid tissue and its current
role in thyroid and parathyroid surgery.
2. Indications for Cryopreservation
2.1. Initial Neck Operations. The clear indication for an
autotransplant of cryopreserved parathyroid tissue is per-
manent postoperative hypoparathyroidism. In the hands
of experienced endocrine surgeons, the risk of permanent
hypocalcemia is ≤1% during initial neck operations. The
risk is particularly low in patients with sporadic primary
hyperparathyroidism (PHPT), most of whom have a single
parathyroid adenoma.
Nonetheless, certain patients have a higher risk of devel-
oping permanent hypoparathyroidism after their initial neck
surgery (Table 1). Most commonly at risk are patients with
multigland parathyroid hyperplasia, especially those with
familial primary hyperparathyroidism [6]. Such patients
may undergo either a subtotal (3.5-gland) parathyroidec-
tomy or a total parathyroidectomy with an immediate
autotransplant. Both a subtotal parathyroidectomy and a
total parathyroidectomy can result in aparathyroidism, so
cryopreservation of parathyroid tissue is recommended at
the time of the initial surgery [6]. In addition, it has been
reported that the use of intraoperative parathyroid hormone
(IOPTH) monitoring during parathyroid surgery can accu-
rately predict patients at risk of developing postoperative
hypocalcemia. A drop of >8 0 %o fI O P T Ha t1 0m i n u t e s
is a signiﬁcant factor for postoperative hypocalcemia [7].
Therefore, cryopreservation of parathyroid tissue should be
considered during parathyroid surgery when the IOPTH
drop >80%.
Patients with end-stage renal disease are at high risk of
developing secondary (SHPT) and tertiary (THPT) hyper-
parathyroidism. Such patients have persistent stimulation
of the parathyroid glands secondary to abnormalities in
the metabolism of calcium, phosphorus, and vitamin D,
resulting in multigland parathyroid hyperplasia. The choice
of operation for such patients can be problematic. They
have an inherently high risk of disease recurrence if a
subtotal parathyroidectomy is performed but a high risk
of permanent hypoparathyroidism if a total parathyroidec-
tomy and an immediate autotransplant are performed [8].
Moreover, such patients may require multiple operations;
to prevent aparathyroidism as a consequence of the initial
or subsequent operations, cryopreservation of parathyroid
tissue is recommended.
Surgical treatment of patients with thyroid disease can
also lead to permanent hypoparathyroidism. The risk of
aparathyroidism is nominal with only a thyroidectomy but
increases with more extensive surgical resections. Routine
central neck dissections for thyroid cancer have a com-
plication rate of permanent hypoparathyroidism of up to
14% [9]. Given such risks, the role of prophylactic central
neck dissections for papillary thyroid cancer continues to
be debated. An immediate intraoperative autotransplant
is preferred during a neck dissection for thyroid cancer,
yet cryopreservation of parathyroid tissue fragments is
also warranted given the multiple operations that may
be required in the future. Subsequent operations increase
the risk of permanent aparathyroidism, an outcome that
cryopreservation of parathyroid tissue may prevent.
2.2. Redo Neck Operations. In contrast to initial neck opera-
tions, the risk of permanent hypocalcemia after a redo neck
operationisnotminuscule,butratherashighas30%[6,10].
The risk of aparathyroidism is higher during a redo neck
operation because the viability of the remaining parathyroid
glands cannot be adequately determined. During the initial
surgery, parathyroid glands left in situ may have unknow-
ingly been devascularized or damaged. During a redo neck
operation, removal or inadvertent injury of any remaining
functional gland may result in permanent hypoparathy-
roidism. This scenario can be particularly problematic in
patients who develop hyperparathyroidism after previously
undergoing a thyroidectomy; during a redo neck operation,
any parathyroid gland removed must be assumed to be the
last viable parathyroid gland and should be autotransplanted
immediately to optimize transplantation success. A fragment
of the parathyroid tissue may be cryopreserved for a possible
delayed autotransplantation if future neck reoperations
result in aparathyroidism.
Other common reasons for parathyroid reoperations
include persistent hyperparathyroidism (hypercalcemia <6
monthsaftertheinitialsurgery)andrecurrenthyperparathy-
roidism (hypercalcemia >6 months after the initial surgery).
Operative success for redo parathyroid surgery is <90%
and is fraught with an 18% rate of causing permanent
hypoparathyroidism [11]. Immediate autotransplantation of
parathyroid tissue to prevent hypoparathyroidism impedes
determination of surgical outcome, which is unpredictable
during redo parathyroid surgery [10]. Accurately assessingInternational Journal of Endocrinology 3
the number of parathyroid glands previously resected, or
the viability of the remaining parathyroid glands, is diﬃcult.
Cryopreservation of parathyroid tissue, rather than an
immediate autotransplant, allows the surgeon to appro-
priately predict surgical outcome, the functionality of any
remaining parathyroid tissue, and the need for a delayed
parathyroid autotransplant.
Operative failure and disease recurrence are infrequent
in patients with sporadic PHPT; reoperations are more
commonly needed in those with SHPT and THPT [8]. Up
to 15% of patients with SHPT and THPT tend to have
more than four parathyroid glands [12], increasing the risk
of operative failure. Cryopreservation of their parathyroid
tissue is especially important, because the long-term renal
eﬀect of prolonged SHPT and THPT predisposes patients
to transient hypocalcemia from bone hunger. Before any
parathyroid autotransplant, it is critical to diﬀerentiate
transient from permanent hypoparathyroidism. Similarly,
patients with thyroid cancer who require repeating oper-
ations are at risk of hypoparathyroidism, because their
remaining parathyroid gland function cannot properly be
assessed.Furthermore,ifparathyroidglandsareimmediately
autotransplanted into the neck muscles during the initial
thyroid surgery, the function of those glands cannot be
properly evaluated [10]. During reoperations for thyroid
cancer,aportionofanyinadvertentlyremovedordevascular-
ized parathyroid glands should be sent for cryopreservation
before any immediate autotransplant. Patients who develop
aparathyroidism during subsequent operations might later
beneﬁt from a delayed autotransplant of the cryopreserved
parathyroid remnant.
3. CryopreservationTechniques
3.1. Tissue Preparation. Intraoperative preparation of
parathyroid tissue is relatively uniform. The parathyroid
tissue removed during surgery is dissected into 30 to 40
pieces of 1 × 1 × 1mm. The pieces are then placed into
a sterile vial containing ice-chilled saline. The vial is then
transported. The supernatant is decanted; about 10 tissue
fragments are transferred into each sterile freezing vial to be
resuspended in the freezing media.
3.2. Freezing Media. The cryopreservation process is vital to
preserving graft functionality. A crucial component is the
freezing medium used during the freezing process. Several
media have been proposed in the literature since the initial
report by Wells et al. [13]. The typical freezing medium
contains Roswell Park Memorial Institute (RPMI) 1640
solution [2, 4, 6, 10, 13–16]. Most institutions use an 80%
RPMI 1640 solution [2, 4, 10, 13], but some use either a 60%
RPMI solution 1640 [15] or no RPMI 1640 solution [17].
In addition, some authors recommend supplementing
the RPMI 1640 solution with 2mM of glutamine [11, 16]
and 5µg/mL of penicillin streptomycin [16]o r5 0 µg/mL
of gentamicin [11]. Dimethyl sulfoxide (DMSO) in a 10%
concentration is added as a cytoplasmic stabilizer [2, 4, 10,
11, 15]. Other reported concentrations of DMSO range from
7.5% to 20% [16, 18]. The last component of the storage
medium is either a 10% to 30% autologous serum [2, 10, 11,
15,16]ora10%to20%fetalbovineserum[4,11].Whenthe
RPMI 1640 solution is excluded, a 90% fetal bovine serum is
used [17].
3.3. Freezing Process. The goal of the freezing process is to
preserve cellular function by maintaining cellular integrity
through the temperature change. To accomplish that goal,
thevialsarecooledslowly,beforebeingtransferredintolong-
term storage. A cooling technique developed at the Mayo
Clinic entails placing the vials in an ice chest ﬁlled with dry
ice prechilled to −55◦Ct o−60◦Cf o r1h o u rt oa l l o wc o o l i n g
by −1◦Cpe rm i n u t e[11]. Otherauthors recommendplacing
the vials in a −60◦C ethyl alcohol bath [10] or in either a
−70◦C[ 15]o ra−80◦C[ 17] freezer overnight. The vials can
alsobeplacedinaprogrammablefreezerandcooledby −1◦C
per minute until a temperature of −80◦Ci sr e a c h e d[ 16].
Once the vials are cooled, they are transferred into a liquid
nitrogen freezer and stored at any of several recommended
temperatures: −170◦C[ 15, 16], −180◦C[ 4, 17], −190◦C
[10], or −196◦C[ 2].
4. AutotransplantTechniques
4.1. Thawing. The vials containing the parathyroid tissue
designated for delayed autotransplantation are removed
from the liquid nitrogen freezer and placed in a warm water
bath. The vials are shaken at 37◦C[ 11, 17]t o4 2 ◦C[ 10] until
the parathyroid tissue fragments are thawed. The fragments
are washed in RPMI 1640 solution at 37◦C three times [10,
11]. Other authors recommend rinsing the fragments ﬁve
times in 1mL of RPMI 1640 solution with a 20% autologous
serum [2]. The RPMI wash is performed to rinse the DMSO,
which is toxic to cells at room temperature.
4.2. Reimplantation. The patient’s nondominant forearm is
chosen for the parathyroid tissue reimplantation under local
anesthesia. A longitudinal incision is made on the forearm.
Dissection is continued until a ﬂexor muscle, preferably the
brachioradialis muscle, is exposed. Bluntly, pockets are cre-
ated in the brachioradialis muscle. One to three parathyroid
graftfragmentsaretransplantedintoseparatemusclepockets
[13]. To maximize the chances of graft function, a total of
20 to 40 fragments are autotransplanted [2, 10]. Care must
be taken to not cause an intramuscular hematoma, which
can compromise graft function. The pockets are closed with
nonabsorbable sutures and marked with a metal clip.
5. FunctionalityTesting Posttransplant
Success posttransplant is determined by the functionality of
the cryopreserved parathyroid tissue graft. Functionality is
determined not only clinically but also biochemically (by
sampling blood from the grafted and nongrafted antecubital
veins, to determine the PTH level at both sites). The
parathyroid graft is reported as fully functional, partially
functional, or nonfunctional (Table 2).4 International Journal of Endocrinology
Table 2: Deﬁnitions of parathyroid graft functionality.
Fully functional
Asymptomatic nonrenal patients
–O ﬀ calcium and vitamin D supplementation
– Eucalcemic with normal PTH levels and/or
grafted-to-nongrafted arm, PTH ratio >1.5 [11]
Renal patients
– PTH levels of 51 to 300pg/mL with normal or decreased calcium levels [18]
Partially functional
Symptomatic nonrenal patients
– On calcium supplementation, with or without vitamin D supplementation
– Hypocalcemic with normal PTH levels and/or grafted-to-nongrafted arm, PTH ratio >1.5 [11]
Renal patients
–P T Hl e v e l so f2 1t o5 0p g / m Lw i t hn o r m a lo rd e c r e a s e dc a l c i u ml e v e l s[ 18]
Nonfunctional
Symptomatic nonrenal patients
– On calcium supplementation, with or without vitamin D supplementation
– Hypocalcemic with low PTH levels and/or grafted-to-nongrafted arm, PTH ratio <1.5 [11]
Renal Patients
– PTH levels <2 0p g / m Lw i t hn o r m a lo rd e c r e a s e dc a l c i u ml e v e l s[ 18]
PTH: parathyroid hormone.
Clinically, the graft is considered fully functional when
the patient remains eucalcemic and asymptomatic—after
all the calcium and vitamin D supplementation has been
discontinued. Complete independence from exogenous sup-
plementation is considered the best evidence of graft func-
tion [10]. A graft is also considered fully functional when
the PTH ratio between the grafted and nongrafted arms is
greater than 1.5—again, after all the calcium and vitamin
D supplementation has been discontinued [11]. Others
recommend a PTH ratio of greater than 2 [10].
The graft is considered partially functional when the
patient continues to require calcium supplementation, with
or without vitamin D supplementation, with a PTH ratio of
greater than 1.5 [11].
The graft is considered nonfunctional when the patient
is hypocalcemic and requires calcium supplementation, with
or without vitamin D supplementation, with a PTH ratio of
less than 1.5.
In renal patients, the functionality of the parathyroid
graft is determined by their PTH levels, independent of
calcium and vitamin D supplementation (since most renal
patients require supplementation) (Table 2)[ 18].
6. Effects of Cryopreservation
The potential beneﬁts of cryopreservation are limited by the
reduced functionality of cryopreserved grafts, as compared
with immediately autotransplanted grafts [11]. Cryopre-
served grafts retain functionality in <70% of patients; fresh
autografts >90% [2, 15]. The cryopreservation process may
induce cellular necrosis and impair cellular viability and,
ultimately, cellular function. The key question is this: does
cell viability determine cell function? Earlier studies found
no diﬀerence in cell viability and secretory capacity between
fresh and cryopreserved parathyroid tissue grafts [6, 19]. Yet
other studies demonstrated that, even though the percentage
of viable cells did not necessarily diﬀer between fresh and
cryopreserved tissue, cryopreservation decreased the total
number of live cells by >70% [4]. That eﬀect on live cell yield
was the same whether the parathyroid tissue was frozen as
tissue fragments or as dispersed cells [4].
Recently, other authors reported that the cryopreser-
vation process decreased total cell viability [15] and that
decreased cell viability was associated with increased storage
time [17]. Functionality also depended on storage time [15].
Both viability and function were drastically reduced with a
storage time of 22 months [15, 17]. To counterbalance the
eﬀects of cellular necrosis, some authors routinely perform
histologic examination of the cryopreserved tissue and auto-
transplant parathyroid tissue according to the percentage
of necrotic cells [2]. In addition, cryopreserved parathyroid
tissue should be utilized as soon as it is deemed necessary,
since a longer storage time limits delayed autotransplant
success.
7. Conclusion
The devastating eﬀect of permanent aparathyroidism has
been, for the most part, ameliorated by parathyroid gland
cryopreservation and delayed autotransplants. Cryopreser-
vation is an extremely valuable tool that is exceedingly
useful in parathyroid surgery. An immediate autotransplant
is preferred during thyroid surgery, yet cryopreservation
of a portion of the parathyroid tissue can also greatly
help patients at high risk of undergoing further surgery.
Cryopreservation allows the clinician to make appropriate
decisions regarding the status of the remaining parathyroid
glands.Suchenhanceddecisionmakingisimportantbecause
most patients undergoing parathyroid and thyroid surgery
experience only transient hypocalcemia. Diﬀerentiating
between transient and permanent hypocalcemia is critical,
especiallyafteraparathyroidectomywhenhypocalcemiamayInternational Journal of Endocrinology 5
result from bone hunger, rather than insuﬃciency of PTH.
Cryopreservation facilitates appropriate surgical and clini-
cal decisions, prevents unnecessary immediate parathyroid
autotransplants,andoﬀersachancetocureaparathyroidism.
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